In vitro metabolism of LVV-Hemorphin-7 by renal cytosol and purified prolyl endopeptidase

被引:16
作者
Fruitier-Arnaudin, I
Cohen, M
Coitoux, C
Piot, JM
机构
[1] Univ Rochelle, Lab Genie Proteique & Cellulaire, F-17042 La Rochelle 1, France
[2] Inst Univ Technol, Dept Genie Biol, F-17026 La Rochelle, France
关键词
hemorphin; peptide hydrolysis; metabolism; homogenate; renal cytosol; subcellular fractions; prolyl endopeptidase;
D O I
10.1016/j.peptides.2003.07.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The metabolism of LVVH7, an endogenous peptide obtained by cathepsin D hydrolysis of the beta chain of hemoglobin, was studied, in vitro, in the presence of cytosol of rat kidney and compared with angiotensin IV. High metabolic activity was found against these two peptides (half life time < 2 min) in this subcellular fraction. The main products of LVVH7 metabolism by renal cytosol are VVH7, H7 and LVVH6 suggesting both aminopeptidase and carboxypeptidase activities. The use of PEP inhibitor in kidney cytosol permitted to demonstrate the major role of prolyl endopeptidase (PEP) in LVVH7 degradation. This fact was reinforced by a kinetic study investigated with purified enzyme (K-m/V-max about 238 mM(-1) s(-1) and close to that observed for angiotensin related peptides). (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1201 / 1206
页数:6
相关论文
共 26 条
[1]   Proline specific peptidases [J].
Cunningham, DF ;
O'Connor, B .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1343 (02) :160-186
[2]   Generation of VV-hemorphin-7 from globin by peritoneal macrophages [J].
Dagouassat, N ;
Garreau, I ;
Sannier, F ;
Zhao, QY ;
Piot, JM .
FEBS LETTERS, 1996, 382 (1-2) :37-42
[3]   Isolation of the opioid peptide Leu-Val-Val-hemorphin-7 from bronchoalveolar lavage fluid of a patient with non-small cell lung cancer [J].
Duethman, D ;
Dewan, N ;
Conlon, JM .
PEPTIDES, 2000, 21 (01) :137-142
[4]  
ERCHEGYI J, 1992, INT J PEPT PROT RES, V39, P477
[5]   Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo:: W-hemorphin-7 [J].
Fruitier, I ;
Garreau, I ;
Piot, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (03) :719-724
[6]   Proteolytic degradation of hemoglobin by endogenous lysosomal proteases gives rise to bioactive peptides: hemorphins [J].
Fruitier, I ;
Garreau, I ;
Lacroix, A ;
Cupo, A ;
Piot, JM .
FEBS LETTERS, 1999, 447 (01) :81-86
[7]   Hemorphins inhibit angiotensin IV binding and interact with aminopeptidase N [J].
Garreau, I ;
Chansel, D ;
Vandermeersch, S ;
Fruitier, I ;
Piot, JM ;
Ardaillou, R .
PEPTIDES, 1998, 19 (08) :1339-1348
[8]   ISOLATION AND CHARACTERIZATION OF A HEMOGLOBIN-DERIVED OPIOID PEPTIDE FROM THE HUMAN PITUITARY-GLAND [J].
GLAMSTA, EL ;
MARKLUND, A ;
HELLMAN, U ;
WERNSTEDT, C ;
TERENIUS, L ;
NYBERG, F .
REGULATORY PEPTIDES, 1991, 34 (03) :169-179
[9]   CONCOMITANT INCREASE IN BLOOD-PLASMA LEVELS OF IMMUNOREACTIVE HEMORPHIN-7 AND BETA-ENDORPHIN FOLLOWING LONG-DISTANCE RUNNING [J].
GLAMSTA, EL ;
MORKRID, L ;
LANTZ, I ;
NYBERG, F .
REGULATORY PEPTIDES, 1993, 49 (01) :9-18
[10]   ISOLATION OF A HEMOGLOBIN-DERIVED OPIOID PEPTIDE FROM CEREBROSPINAL-FLUID OF PATIENTS WITH CEREBROVASCULAR BLEEDINGS [J].
GLAMSTA, EL ;
MEYERSON, B ;
SILBERRING, J ;
TERENIUS, L ;
NYBERG, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :1060-1066